glp 1 korea South warns teens of GLP-1 obesity drug risks and tightens prescription monitoring Korea Ginseng Corp launches blood

[PMC free article] [PubMed] [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article.

No, lower back pain is not listed as a common or recognized side effect in FDA prescribing information for semaglutide (Ozempic, Wegovy, Rybelsus)

Key benefits include weight loss of up to 30 pounds in the first three months, better appetite control, reduced cravings, improved insulin sensitivity and blood sugar levels, and steady, sustainable fat loss rather than rapid, temporary changes

Those who continued lost an additional 5.5% over the next year

Clinical studies have shown that weekly injections can lead to an average weight loss of 9-13% over a year when combined with healthy lifestyle habits